Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jacquelyn W Chou

Showing results (1-10 of 23) with videos related to

Pageof 3
Sort By:
F1000Research|August 7, 2018
Unintended consequences of the potential phase-out of gamma irradiationJacquelyn W Chou, Michelle Skornicki, Joshua T Cohen
BMC Health Services Research|March 2, 2019
Short-term budget affordability of hepatitis C treatments for state Medicaid programsJacquelyn W Chou, Alison R Silverstein, Dana P Goldman
Forum for Health Economics & Policy|August 18, 2019
Public-Private Partnership as a Path to Affordable Healthcare in Emerging MarketsJacquelyn W Chou, Darius N Lakdawalla, Jacqueline Vanderpuye-Orgle
Therapeutic Advances in Hematology|July 19, 2021
The value of survival gains from therapeutic innovations for US patients with relapsed/refractory multiple myelomaJoanna P MacEwan, Istvan Majer, Jacquelyn W Chou, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|May 25, 2025
Implementing the Generalized Risk-Adjusted Cost-Effectiveness Model for Sickle Cell Disease: A Case StudyMarlon Graf, Joris Kleintjens, Md Tahsin Hasan, et al.
The American Journal of Managed Care|January 3, 2024
Generalized cost-effectiveness analysis to assess treatment value in hepatitis CJacquelyn W Chou, Marlon Graf, Oliver Díaz Espinosa, et al.
The International Journal of Neuroscience|May 26, 2020
Challenges and opportunities in insomnia disorderMeaghan Roach, Timothy Juday, Rifat Tuly, et al.
Health Affairs (Project Hope)|October 7, 2015
Broad Hepatitis C Treatment Scenarios Return Substantial Health Gains, But Capacity Is A ConcernKaren Van Nuys, Ronald Brookmeyer, Jacquelyn W Chou, et al.
Cancer Management and Research|December 15, 2017
The effect of medication nonadherence on progression-free survival among patients with renal cell carcinomaJason Shafrin, Jeffrey Sullivan, Jacquelyn W Chou, et al.
Journal of Health Economics|December 20, 2016
The role of imperfect surrogate endpoint information in drug approval and reimbursement decisionsKatalin Bognar, John A Romley, Jay P Bae, et al.
Pageof 3

Showing results (1-10 of 23) with videos related to

Sort By:
Pageof 3
F1000Research|August 7, 2018
Unintended consequences of the potential phase-out of gamma irradiationJacquelyn W Chou, Michelle Skornicki, Joshua T Cohen
BMC Health Services Research|March 2, 2019
Short-term budget affordability of hepatitis C treatments for state Medicaid programsJacquelyn W Chou, Alison R Silverstein, Dana P Goldman
Forum for Health Economics & Policy|August 18, 2019
Public-Private Partnership as a Path to Affordable Healthcare in Emerging MarketsJacquelyn W Chou, Darius N Lakdawalla, Jacqueline Vanderpuye-Orgle
Therapeutic Advances in Hematology|July 19, 2021
The value of survival gains from therapeutic innovations for US patients with relapsed/refractory multiple myelomaJoanna P MacEwan, Istvan Majer, Jacquelyn W Chou, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|May 25, 2025
Implementing the Generalized Risk-Adjusted Cost-Effectiveness Model for Sickle Cell Disease: A Case StudyMarlon Graf, Joris Kleintjens, Md Tahsin Hasan, et al.
The American Journal of Managed Care|January 3, 2024
Generalized cost-effectiveness analysis to assess treatment value in hepatitis CJacquelyn W Chou, Marlon Graf, Oliver Díaz Espinosa, et al.
The International Journal of Neuroscience|May 26, 2020
Challenges and opportunities in insomnia disorderMeaghan Roach, Timothy Juday, Rifat Tuly, et al.
Health Affairs (Project Hope)|October 7, 2015
Broad Hepatitis C Treatment Scenarios Return Substantial Health Gains, But Capacity Is A ConcernKaren Van Nuys, Ronald Brookmeyer, Jacquelyn W Chou, et al.
Cancer Management and Research|December 15, 2017
The effect of medication nonadherence on progression-free survival among patients with renal cell carcinomaJason Shafrin, Jeffrey Sullivan, Jacquelyn W Chou, et al.
Journal of Health Economics|December 20, 2016
The role of imperfect surrogate endpoint information in drug approval and reimbursement decisionsKatalin Bognar, John A Romley, Jay P Bae, et al.
Pageof 3